The objective of this randomized double-blind placebo controlled trial is to investigate the effect of genistein supplementation on indicators of blood glucose, serum lipid profile, oxidative stress status in postmenopausal women with type-2 diabetes. postmenopausal women with type-2 diabetes, will be recruited from Doctor Gholipour Hospital in Boukan including 60 individual. Subjects will be randomly assigned to receive either 54mg genistein oral tablet or placebo tablets for 3 month. Anthropometric measurements (weight, height, waist and hip circumference, waist to hip ratio) and biochemical parameters (lipid profile including total cholesterol, LDL and HDL cholesterol and triglyceride concentrations, fasting glucose and insulin level, HbA1C, and TAC, MDA levels), As well as insulin resistance and insulin sensitivity will be evaluated by using HOMA-IR and QUICKI index respectively. dietary data obtained from 3-day food records will be measured before and after treatment and compared between groups. And the data will be analyzed by using appropriate statistical methods.